The MD Anderson program wouldn't be considered a particularly important program in the scheme of everything by many, or I wouldn't think so at any rate.
The shelving was likely due to cost or bang for buck I'm thinking, but we will find out more when Steven next speaks...Even though the costs were shared, cell manufacturing isn't cheap and perhaps the expenses were exceeding original expectations?
With the share price, my guess is a broker may be shaking the tree.
It's up to Steven to clear everything up for shareholders, at the moment with the exception of PTX-100 is feels like the whole company is in stealth mode.
Will PTX-200 be shelved? What's next for this program?
What's the status of the Thermo Fisher investigation?
When will OmniCAR be hitting phase 1 trials?
Time to bring shareholders back into the fold.
The bright light is the cash position of $20m with a low burn rate.
The MD Anderson program wouldn't be considered a particularly...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(4.17%) |
Mkt cap ! $37.04M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.6¢ | $94.55K | 2.033M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 550000 | 2 |
View Market Depth
| Last trade - 15.36pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.8¢ |
Change
-0.002 ( 2.04 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.8¢ | 4.5¢ | 409565 | ||
| Last updated 15.51pm 03/05/2024 ? | |||||
| PTX (ASX) Chart |